J2KBIO Co., Ltd. (KOSDAQ: 420570)
South Korea
· Delayed Price · Currency is KRW
17,880
-150 (-0.83%)
Oct 11, 2024, 9:00 AM KST
J2KBIO Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Oct '24 Oct 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Debt / Equity Ratio | 0.12 | 0.07 | 0.42 | 0.59 | 0.69 |
Debt / EBITDA Ratio | 0.45 | 0.20 | 1.59 | 2.20 | 3.45 |
Debt / FCF Ratio | -34.74 | 0.65 | 3.46 | 4.36 | -4.97 |
Asset Turnover | 1.27 | 1.44 | 0.95 | 0.97 | - |
Inventory Turnover | 8.59 | 6.47 | 5.03 | 7.59 | - |
Quick Ratio | 5.54 | 2.90 | 2.52 | 2.37 | 2.51 |
Current Ratio | 6.45 | 3.78 | 3.26 | 2.87 | 3.02 |
Return on Equity (ROE) | 4.42% | 33.43% | 20.83% | 20.06% | - |
Return on Assets (ROA) | 15.27% | 17.69% | 8.60% | 7.97% | - |
Return on Capital (ROIC) | 17.31% | 20.29% | 9.79% | 8.85% | - |
Payout Ratio | 0.00% | 4.96% | - | - | - |
Buyback Yield / Dilution | 0.41% | -3.97% | -8051.19% | - | - |
Total Shareholder Return | 0.41% | -3.97% | -8051.19% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.